在25年内将心力衰竭死亡率降低25%:"25in25"心力衰竭峰会
Lucy Beishon1, Rebecca Jayasinghe2, Shahbaz Roshan-Zamir3
1NIHR Academic Clinical Lecturer NIHR Leicester Biomedical Research Centre, BHF Cardiovascular Research Centre, Glenfield Hospital, Groby Road, Leicester, LE3 9QP.
The British journal of cardiology
|November 18, 2024
概括
心力衰竭 (HF) 在老年人中很常见,但经常被忽视. 改善早期检测和治疗,以及患者赋权,可以显著减少心力衰竭死亡人数.
科学领域:
- 老年病的医生 老年病的医生
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 显著影响老年人,导致发病率和死亡率.
- 尽管取得了进展,但HF在老年人群中仍未得到充分诊断和治疗.
- 人口老龄化需要改进高频管理策略.
研究的目的:
- 思考在英国心力衰竭协会"25in25"峰会上确定的优先事项.
- 讨论老年人早期HF检测和管理的障碍.
- 探索患者赋权在改善老年人医疗保健方面的作用.
主要方法:
- 专家评论反映了一个跨学科峰会.
- 讨论HF检测和治疗当前的挑战.
- 对改善HF老年患者治疗结果的策略的分析.
主要成果:
- 确定了改善HF结果的重点优先事项.
- 突出了老年人早期检测和治疗高温风暴的障碍.
- 强调了患者赋权的潜力,以改善护理.
结论:
- 早期检测和改善高风的治疗可以降低老年人死亡率.
- 解决老年人高压管理中的障碍和复杂性至关重要.
- 患者赋权对于改善老年人群中HF护理结果至关重要.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Heart Failure Drugs: β-Blockers
319
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
319
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Heart Failure Drugs: Diuretics
345
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
345
Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K


